Schedule 13G Filing by Long Path Smaller Companies Fund, LP

This filing reports that Long Path Smaller Companies Fund, LP, along with its general partner Long Path Fund GP, LLC, its investment adviser Long Path Partners, LP, its general partner Long Path Holdings LLC, and individuals William Thomas Brennan and Brian Paul Nelson, have acquired a 5.6% stake in Mesa Laboratories, Inc. The acquisition represents 311,703 shares. The filing indicates that these securities were not acquired for the purpose of influencing the control of the issuer. The shares were acquired as of March 11, 2026, with the filing date being March 13, 2026. The total number of outstanding shares of Common Stock as of January 31, 2026, was 5,524,813.